We assessed the correlation between ligase chain reaction (LCR) on first void urine (FVU) and cultures of urethral and cervical swabs to detect chlamydia during three posttreatment follow up visits for 10 men and 19 women with genital chlamydial infections who had been treated with azithromycin or doxcycline.T he most common sexually transmitted bacterial infection in North America is Chlamydia trachomatis. 1 Highest rates of infections occur among young adults aged 15-24, and rates are often higher in females than males. Infections are often asymptomatic, and if untreated, may lead to upper genital tract complications of proctitis and epididymitis in men, and pelvic inflammatory disease, endometritis, salpingitis, ectopic pregnancy, and tubal factor infertility in women. 2 Rates of recurrence or persistence of chlamydial infection in young women have been estimated to range from 4.1% to 13.4%. 3 Current treatment guidelines in Canada and the United States for C trachomatis infections recommend oral treatment with a 7 day course of doxycycline or a single dose of azithromycin. Studies have demonstrated comparable cure rates for both single and multidose therapy. 4 Ligase chain reaction (LCR) testing of first void urine (FVU) to detect C trachomatis is an alternative to swab testing, especially in settings where most individuals are asymptomatic, or where patients are unlikely to agree to a pelvic examination or urethral swab. 5 Other nucleic acid amplification (NAA) tests such as polymerase chain reaction (PCR) and transcription mediated amplification (TMA) have demonstrated similar efficacy on FVU and some data are available on the role of NAA assays as tests of cure. 6-8
METHODS
Patient selectionTen men and 19 women, who were confirmed positive for C trachomatis by EIA or culture and were positive in FVU tested by LCR at baseline, were recruited from STD clinics which participated in a multicentre randomised controlled trial in Vancouver, British Columbia, Sherbrooke, Quebec, Laval, Quebec, and Regina, Saskatchewan. That trial compared the efficacy, safety, and tolerance of azithromycin (1 g single dose) and doxycycline (100 mg twice daily for 7 days). Men with symptoms (urethral discharge, dysuria or urethral irritation) and a urethral smear negative for Neisseria gonorrhoeae, showing >4 polymorphonuclear neutrophils (PMN) per high power field were eligible. Women with an endocervical smear showing >10 PMN per high power field or with a positive chlamydia enzyme immunoassay (EIA) or culture were also eligible. All subjects gave written informed consent, which was approved by the institutional review board at each participating institution.All 29 patients returned for at least two of the three follow up visits at 8, 28, and 42 days after treatment had begun.
Clinical visitsAt the initial visit each patient underwent a physical examination and a medical history was taken. A clinical examination was performed, documenting urethral discharge, dysuria, and urethral irritation in men and purulent or mucopurulent di...